---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000128"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-05-18T12:32:42+00:00"
generated_at: "2026-05-18T12:36:03.502837+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Clover Health publishes supplemental Q&A for Q1 2026; no specific financial details in filing excerpt

## Summary
- Company furnished a supplemental Q&A document responding to shareholder questions about Q1 2026 earnings.
- No numerical data, guidance changes, or material updates are present in the provided exhibit excerpt.
- CEO Andrew Toy reiterated commitment to transparency and shareholder engagement.
- Document is available on the investor relations section of Clover Health's website.

## SEC filing metadata
- accession: 0001801170-26-000128
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-05-18T12:32:42+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/0001801170-26-000128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/clov-20260518.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000128
- JSON: https://secwatch.observer/filing/0001801170-26-000128.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000128.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.